A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
SalivaDirect
MessageFact Sheet for Health Care Providers:
SalivaDirect - Healthcare Provider Fact Sheet (fda.gov)
Fact Sheet for Patients:
SalivaDirect - Patient Fact Sheet (yale.edu)
SalivaDirect - Healthcare Provider Fact Sheet (fda.gov)
Fact Sheet for Patients:
SalivaDirect - Patient Fact Sheet (yale.edu)
Test Code
30089
Alias/See Also
COVID-19
SARS-CoV-2
Coronavirus
SARS-CoV-2
Coronavirus
CPT Codes
U0004
Preferred Specimen
Saliva
Patient Preparation
For at least 30 minutes prior to collection:
DO NOT
1. eat or drink
2. smoke
3. clean your teeth
4. chew gum
5. use nasal sprays
Minimum Volume
0.5 mL
Instructions
Allow saliva to pool in mouth, and gently allow saliva to pass into the collection tube. Do this until the minimum volume has been acheived.
*avoid coughing or sniffing
*do not 'spit' into the container so that droplets and aerosols are minimized.
*avoid coughing or sniffing
*do not 'spit' into the container so that droplets and aerosols are minimized.
Transport Temperature
Room Temperature
Specimen Stability
5 Days
Methodology
RT-qPCR
SalivaDirect™ has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
FDA Status
EUA
Performed By
CoxHealth
Performing Laboratory
Cox South